发明人郑宇鹏,黄志刚,马晓峰. "Method for the Synthesis of 3,6-Dichloroimidazo[1,2-a]pyrazine" [P]. 中国发明专利, 专利号 CN 109028260 A, 授权公告日 2020-01-06.
发明人唐晓军,郑宇鹏,郭海燕. "A Process for Preparing High-Purity 3,6-Dichloroimidazo[1,2-a]pyrazine" [P]. 中国发明专利, 专利号 CN 114095403 A, 授权公告日 2022-05-14.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2020, 2454, (9), 5643-5665.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2019, 2371, (4), 2864-2872.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of 3,6-Dichloroimidazo[1,2-a]pyrazine Using HRMS and NMR". Anal. Chim. Acta, 2015, 639, 5850-5872.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2011, 1709, (5), 4274-4296.